Vol. 68 No. 2 (2022), REVIEWS

Vol. 68 No. 2 (2022)

Surgical management options in lung cancer with malignant pleural disease

REVIEWS

https://doi.org/10.37469/0507-3758-2022-68-2-149-158

Published 06.05.2022

Аndrey Аrseniev
Andrey Nefedov
Sergey Novikov
Anton Barchuk
Sergey Tarkov
Sergey Kanaev
Kirill Kostitsyn
Alina Nefedova
Ketevan Gagua
Nikolay Aristidov

Аndrey Аrseniev

Andrey Nefedov

Sergey Novikov

Anton Barchuk

Sergey Tarkov

Sergey Kanaev

Kirill Kostitsyn

Alina Nefedova

Ketevan Gagua

Nikolay Aristidov

##article.numberofdownloads## 53

##article.numberofviews## 230

pdf (Русский)

Keywords

non-small cell lung cancer,
malignant pleural disease,
malignant pleural effusion,
radical surgical management,
personalisation,
prognostic and predictive factors

How to Cite

Аrseniev А., Nefedov , A., Novikov , S., Barchuk , A., Tarkov , S., Kanaev , S., Kostitsyn , K., Nefedova , A., Gagua , K., & Aristidov , N. (2022). Surgical management options in lung cancer with malignant pleural disease. Voprosy Onkologii, 68(2), 149–158. https://doi.org/10.37469/0507-3758-2022-68-2-149-158

Abstract

This review discusses surgical management options, both radical and palliative surgical management for malignant pleural disease in lung cancer. No current clinical guideline recommends their routine implementation. Nevertheless, radical surgical management is used to improve the long-term results for patients with malignant pleural disease. The observational data suggest the effectiveness is not apparent, which is also associated with the patients’ heterogeneity and surgical methods. Most experts agree that it is impossible to draw well-grounded conclusions about the feasibility, efficacy, safety and optimal scope for surgical interventions in lung cancer patients with malignant pleural diseases. They advocate further research and randomised trials, considering the expected potential of using modern multidisciplinary approaches. When determining the tactics of malignant pleural disease management, an individual approach is required. It is crucial to consider the most significant prognostic and predictive factors: laterality, tumour spread (distant and regional metastases), sex, age, comorbidities, morphology, the presence of driver mutations, and the risk of postoperative complications. Personalisation of methods for managing malignant pleural disease in lung cancer is a promising area of modern oncology. However, many aspects of approaches to solving this problem remain unclear and require further research.

https://doi.org/10.37469/0507-3758-2022-68-2-149-158

##article.numberofdownloads## 53

##article.numberofviews## 230

pdf (Русский)

References

Арсеньев А.И., Нефедов А.О., Левченко Е.В. и соавт. Оптимизация методов лечения хирургических осложнений при раке лёгкого // Вопросы онкологии. 2012;58(5):674–679.

Arrieta O, Escamilla-López I, Lyra-González I et al. Radical aggressive treatment among non-small cell lung cancer patients with malignant pleural effusion without extra-thoracic disease // J. Thorac. Dis. 2019;11(2):595–601.

Bibby AC, Dorn P, Psallidas I et al. ERS/EACTS statement on the management of malignant pleural effusions // Eur. Respir. J. 2018;52:1800349. doi:10.1183/13993003.00349-2018

Chiang CL, Wang LC, Ho HL et al. Effect of postoperative systemic therapy on pulmonary adenocarcinoma with unexpected pleural spread detected during thoracotomy or thoracoscopy // Oncotarget. 2017;9(4):5435–5444.

Chikaishi Y, Shinohara S, Kuwata T et al. Complete resection of the primary lesion improves survival of certain patients with stage IV non-small cell lung cancer // J. Thorac. Dis. 2017;9(12):5278–5287.

Dai C, Ren Y, Xie D et al. Does lymph node metastasis have a negative prognostic impact in patients with NSCLC and M1a disease? // J. Thorac. Oncol. 2016;11(10):1745–1754.

Dall K, Ford C, Fisher R, Dunningc J. Is there a survival advantage of incomplete resection of non-small-cell lung cancer that is found to be unresectable at thoracotomy? // Interact. Cardiovasc. Thorac. Surg. 2013;16(4):529–532.

David EA, Clark JM, Cooke DT et al. The Role of Thoracic Surgery in the Therapeutic Management of Metastatic Non-Small Cell Lung Cancer // J. Thorac. Oncol. 2017;12(11):1636–1645.

Feller-Kopman DJ, Reddy CB et al. On behalf of the American Thoracic Society, Society of Thoracic Surgeons, and Society of Thoracic Radiology. Management of Malignant Pleural Effusions. An Ofﬁcial ATS/STS/STR Clinical Practice Guideline // Am. J. Respir. Crit. Care Med. 2018;198(7):839–849.

Fukui T, Yokoi K. The role of surgical intervention in lung cancer with carcinomatous pleuritic // J. Thorac. Dis. 2016;8(11):901–907.

Fukuse T, Hirata T, Tanaka F, Wada H. The prognostic significance of malignant pleural effusion at the time of thoracotomy in patients with non-small cell lung cancer // Lung Cancer. 2001;34(1):75–81.

Go T, Misaki N, Matsuura N et al. Role of surgery in multi-modality treatment for carcinomatous pleuritic in patients with non-small cell lung cancer // Surg. Today. 2015;45(2):197–202.

Guinde J, Georges S, Bourinet V et al. Recent developments in pleurodesis for malignant pleural disease // Clin. Respir. J. 2018;12:2463–2468.

Ichinose Y, Tsuchiya R, Koike T et al. The prognosis of patients with non-small cell lung cancer found to have carcinomatous pleuritic at thoracotomy // Surg. Today. 2000;30(12):1062–1066.

Ichinose Y, Tsuchiya R, Koike T et al. Prognosis of resected non-small cell lung cancer patients with carcinomatous pleuritis of minimal disease // Lung Cancer. 2001;32(1):55–60.

Iida T, Shiba M, Yoshino I et al. Surgical intervention for non-small-cell lung cancer patients with pleural carcinomatosis: results from the Japanese Lung Cancer Registry in 2004 // J. Thorac. Oncol. 2015;10(7):1076–1082.

Jin WB, Liang CY, Peng YH, Zhou N.K. Pleuropneumonectomy for diffuse pleural metastasis in primary lung cancer // J. Cancer. Res. Ther. 2013;9:92–97.

Koegelenberg CFN, Shaw JA, Irusen E.M, Gary Lee YC. Contemporary best practice in the management of malignant pleural effusion // Ther. Adv. Respir. Dis. 2018;12:1–13.

Kodama K, Higashiyama M, Okami J et al. Cytoreductive surgery and post-operative heated pleural chemotherapy for the management of pleural surface malignancy // Int. J. Hyperthermia. 2013;29(7):653–662.

Li C, Kuo SW, Hsu HH et al. Lung adenocarcinoma with intraoperatively diagnosed pleural seeding: is main tumor resection beneficial for prognosis? // J. Thorac. Cardiovasc. Surg. 2018;155(3):1238–1249.

Li H, Sun Z, Yang F et al. Primary tumour resection in non-small-cell lung cancer patients with ipsilateral pleural dissemination (M1a): a population-based study // Eur. J. Cardiothorac. Surg. 2019;55(6):1121–1129.

Li S, Zhang S, Huang M et al. Management of occult malignant pleural disease firstly detected at thoracotomy for non-small cell lung cancer patients // J. Thorac. Dis. 2019;9(10):1121–1129.

Liu T, Liu H, Wang G. Survival of M1a non-small cell lung cancer treated surgically: a retrospective single-center study // Thorac. Cardiovasc. Surg. 2015;63(7):577–582.

Migliore M, Calvo D, Criscione A et al. Cytoreductive surgery and hyperthermic intrapleural chemotherapy for malignant pleural diseases: preliminary experience // Future Oncol. 2015;11:47–52.

Mordant P, Arame A, Foucault C et al. Surgery for metastatic pleural extension of non-small-cell lung cancer // Eur. J. Cardiothorac. Surg. 2011;11:47–52.

Morgensztern D, Waqar S, Subramanian J et al. Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer // J. Thorac. Oncol. 2019;7(10):1485–1489.

Okamoto T, Iwata T, Mizobuchi T et al. Pulmonary resection for lung cancer with malignant pleural disease first detected at thoracotomy // Eur. J. Cardiothorac. Surg. 2012;41(1):25–30.

Ost DE, Niu J, Zhao H et al. Quality Gaps and Comparative Effectiveness of Management Strategies for Recurrent Malignant Pleural Effusions // Chest. 2018;153(2):438–452.

Porcel JM, Lui MMS, Lerner AD et al. Comparing approaches to the management of malignant pleural effusions // Expert Review of Respiratory Medicine. 2017. doi:10.1080/17476348.2017.1300532

Ren Y, Dai C, Shen J et al. The prognosis after contraindicated surgery of NSCLC patients with malignant pleural effusion (M1a) may be better than expected // Oncotarget. 2016;7(18):26856–26865.

Ren YJ, She YL, Dai CY et al. Primary tumour resection showed survival benefits for non-small-cell lung cancers with unexpected malignant pleural dissemination // Interact. CardioVasc. Thorac. Surg. 2016;22(3):321–326.

Ryu JS, Ryu HJ, Lee SN et al. Prognostic impact of minimal pleural effusion in non-small-cell lung cancer // Clin Oncol. 2014;32(9):960–967.

Sawabata N, Matsumura A, Motohiro A et al. Malignant minor pleural effusion detected on thoracotomy for patients with non-small cell lung cancer: is tumor resection beneficial for prognosis? // Ann. Thorac. Surg. 2002;73(2):412–415.

Shen H, Cao Y, Li X. et al. Surgical Intervention Improves Survival for Metastatic Non-Small Cell Lung Cancer Patients // Medicine (Baltimore). 2016;95(21):3800.

Shiba M, Kakizawa K, Kohno H et al. Prognostic implication of Ki-67 immunostaining in treating subclinical pleural cancer found at thoracotomy in lung cancer patients // Ann. Thorac. Surg. 2001;71(6):1765–1771.

Xu Y, Chen N, Wang Z et al. Should primary tumor be respected for non-small cell lung cancer with malignant pleural disease unexpectedly found during operation? —a systemic review and metaanalysis // J. Thorac. Dis. 2016;8(10):2843–2852.

Yamaguchi M, Ichinose Y, Shimamatsu S et al. Preoperative concurrent chemoradiotherapy followed by extrapleural pneumonectomy for patients with non-small cell lung cancer with malignant pleural effusion and/or pleural nodules: ten-year results of a prematurely terminated single institute phase II trial // Surg. Oncol. 2015;24(2):78–83.

Yokoi K, Matsuguma H. Surgical treatment of lung cancer with carcinomatous pleuritic // Nihon Geka Gakkai Zasshi. 2013;114(4):196–200.

Yun JK, Kim MA, Choi CM et al. Surgical outcomes after pulmonary resection for non–small cell lung cancer with localized pleural seeding first detected during surgery // Thorac. Cardiovasc. Surg. 2018;66(2):142–149.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

Vakhtang Merabishvili, Iuliia Iurkova, Aleksandr Shcherbakov, Evgenii Levchenko, Anton Barchuk, Nikolai Krotov, Elvira Merabishvili, Lung cancer (C33, 34). Morbidity, mortality, accuracy of registration, localization and histological structure (population study) , Voprosy onkologii : Vol. 67 No. 3 (2021)
Игорь Чумаченко, Roman Murashko, Arthur Keshabyan, Petr Krivorotko, Sergey Novikov, Benefits of Intraoperative Radiation Therapy in the combined treatment of breast cancer , Voprosy onkologii : Vol. 69 No. 1 (2023)
Sergey Novikov, Roman Novikov, Nikolay Ilin, Yuriy Merezhko, Ekaterina Samartseva, Andrey Arseniev, Vladimir Protoschak, Vasiliy Karandashov, The first experience of clinical application of an animal collagen-based spacer of domestic production to optimize the radiation treatment for prostate cancer: indications, technique and complications , Voprosy onkologii : Vol. 68 No. 6 (2022)
Anton Zozulya, Sergey Novikov, Irina Baldueva, D. Girdyuk, Natalya Yemelyanova, Yelena Tyuryaeva, E. Fedosova, F. Antipov, A. Navoloka, Sergey Kanaev, Aleksey Belyaev, CHANGES IN THE IMMUNE STATUS OF PATIENTS WITH METASTATIC SOLID TUMORS DURING STEREOTACTIC RADIATION THERAPY , Voprosy onkologii : Vol. 66 No. 3 (2020)
Аndrey Аrseniev , Sergey Novikov, Sergey Kanaev, Evgeny Arsenyev, Sergey Tarkov , Anton Barchuk , Yuliya Melnik, Andrey Nefedov , Roman Novikov, Anton Zozulya , Ketevan Gagua , Nikolay Aristidov , Filipp Antipov , Yuri Merezhko , Nikolay Ilyin , Vascular mechanisms in the radiobiological effects from high-dose radiotherapy (literature review) , Voprosy onkologii : Vol. 69 No. 2 (2023)
Igor Berlev, Yu. Trifanov, Sergey Kanaev, Adiliya Urmancheeva, Nikolay Mikaya, Yevgeniya Bezhanova, Yekaterina Nekrasova, Gayk Mkrtchyan, Tatyana Rogovskaya, Pavel Krzhivitskiy, Sergey Novikov, Tatyana Gorodnova, Katran Guseynov, Zaur Ibragimov, Yelena Ulrikh, R. Akhmerov, POSSIBILITIES OF DETECTION OF SENTINEL LYMPH NODES IN ENDOMETRIAL CANCER BY RADIOISOTOPE AND FLUORESCENT (ICG) METHODS , Voprosy onkologii : Vol. 63 No. 2 (2017)
Andrey Arsenyev , Sergey Kanaev , Evgeny Arsenyev, Sergey Tarkov , Anton Barchuk , Yulia Melnik, Andrey Nefedov, Roman Novikov , Ketevan Gagua , Nikolay Aristidov , Nikolay Ilyin , Philip Antipov , Yuri Merezhko , Anton Zozulya , Sergey Novikov , Linear-quadratic model in the description of the mechanisms of high-dose radiation therapy , Voprosy onkologii : Vol. 68 No. 6 (2022)
A. Arseniev, A. Nefedova, A. Ganeeva, A. Nefedov, S. Novikov, Anton Barchuk, S. Kanaev, I. Jahatspanian, A. Gubal, A. Kononov, S. Tarkov, N. Aristidov, COMBINED DIAGNOSTICS OF LUNG CANCER USING EXHALED BREATH ANALSYSIS AND SPUTUM CYTOLOGY , Voprosy onkologii : Vol. 66 No. 4 (2020)
Anton Barchuk, A. Atroshchenko, V. Gaydukov, P. Vinogradov, Sergey Tarakanov, Sergey Kanaev, Andrey Arsenev, Yuriy Komarov, Mikhail Kharitonov, Aleksey Barchuk, Vakhtang Merabishvili, Vladimir Kuznetsov, Vladimir Trofimov, Nataliya Gusarova, Igor Kotsyuba, Aleksey Belyaev, Maksim Podolskiy, A. Nefedova, AUTOMATED DIAGNOSIS IN A POPULATION-BASED SCREENING FOR LUNG CANCER , Voprosy onkologii : Vol. 63 No. 2 (2017)
Andrey Arseniev , Sergey Novikov, Sergey Kanaev , Evgeny Arseniev, Sergey Tarkov, Anton Barchuk, Yulia Melnik, Andrey Nefedov, Roman Novikov, Anton Zozulya, Nikolay Aristidov, Filipp Antipov, Yuriy Merezhko, Nikolay Ilyin, Zhanna Bryantseva, Irina Akulova , The Non-Targeted Abscopal Effect in High Dose-Rate Radiobiology , Voprosy onkologii : Vol. 69 No. 4 (2023)

<< < 1 2 3 4 5 > >>